Skip to content
AnalystLens

Omega Healthcare Investors 8-K Report, Agreement Terminated (Oct 15, 2025)

Reports
Material Agreements
Filing Date
Filed October 15, 2025
Period End
October 15, 2025
Security
OHI
In the record · 2016–202610-K1210-Q348-K126

OHI filed 12 annual reports (10-K), 34 quarterly reports (10-Q) and 126 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · May ’17May ’17
  2. Material agreement8-K · Oct ’20Oct ’20
  3. Leadership change8-K · Jan ’23Jan ’23
  4. Leadership change8-K · Oct ’26Oct ’26

Summary

Summary of the 8-K filed October 15, 2025. Cited figures are marked; the original filing is the authoritative source.

Omega Healthcare Investors, Inc. ("Omega") reported under Item 1.02 (Termination of a Material Definitive Agreement) that on October 15, 2025 it redeemed all of its outstanding $600 milliona aggregate principal amount of 5.250% Senior Notes due 2026 (the "Notes").

The Notes were issued under an Indenture dated as of September 23, 2015, with U.S. Bank Trust Company, National Association as Trustee, and were guaranteed by certain of Omega's subsidiaries. As previously reported, the Trustee notified holders on September 15, 2025 of Omega's election to redeem the Notes on October 15, 2025. On that date Omega irrevocably deposited $607,875,000b with the Trustee to pay the redemption price, which equaled 100% of principal plus accrued and unpaid interest to, but not including, the redemption date.

As a result, Omega's and the subsidiary guarantors' obligations under the Notes, the Indenture and the related guarantees terminated, and the Indenture was discharged, though customary provisions on Trustee compensation, indemnification and application of trust money survive. For investors, this is a routine debt retirement that removes the $600 millionc 2026 maturity from Omega's capital structure. The filing also discloses that U.S. Bank Trust Company, National Association has performed corporate trust services for Omega for customary compensation and may do so again.

Key Highlights

  1. Omega redeemed all $600 million aggregate principal amount of its 5.250% Senior Notes due 2026 on October 15, 2025.
  2. Omega irrevocably deposited $607,875,000 with the Trustee to fund the redemption price.
  3. The redemption price was 100% of principal plus accrued and unpaid interest to, but not including, the redemption date.
  4. The Trustee gave notice of the redemption election to holders on September 15, 2025, as previously reported.
  5. The Indenture dated September 23, 2015 was discharged, and obligations of Omega and its subsidiary guarantors under the Notes and guarantees terminated.
  6. Certain Indenture provisions covering Trustee compensation, indemnification and application of trust money survive the discharge.
  7. The filing was signed by Robert O. Stephenson, Chief Financial Officer.

Frequently Asked Questions

  1. What debt did Omega Healthcare Investors redeem?

    Omega redeemed all $600 million aggregate principal amount of its outstanding 5.250% Senior Notes due 2026.

  2. How much did Omega pay to redeem the Notes?

    Omega irrevocably deposited $607,875,000 with the Trustee, covering 100% of the principal amount plus accrued and unpaid interest to, but not including, the redemption date.

  3. Does the redemption end Omega's obligations under the Notes?

    Yes. Omega's and its subsidiary guarantors' obligations under the Notes, the Indenture and the subsidiary guarantees were terminated and the Indenture was discharged, although certain customary Trustee provisions survive.

  4. When was the redemption notice given?

    The Trustee gave notice to holders on September 15, 2025, at Omega's direction, of its election to redeem all of the Notes on October 15, 2025.

  5. Does Omega have a relationship with the Trustee beyond this debt?

    Yes. U.S. Bank Trust Company, National Association has performed corporate trust services for Omega from time to time for customary compensation and may do so again in the future.